Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay.

计划入组 160 人 · 首次发布于 2026 年 5 月 14 日

Study of Clinical Non-inferiority of Actparin® (Laboratorio Bergamo) Compared to Heparin Sodium (APP Pharmaceuticals), in Patients With Chronic Renal Failure

计划入组 132 人 · 首次发布于 2011 年 5 月 2 日

Autoimmune Hepatitis Study

计划入组 100 人 · 首次发布于 2006 年 2 月 3 日

Interleukin-2 biosimilar (Laboratorio Varifarma)

Filgrastim biosimilar(Laboratorio Varifarma SA)

Interferon alpha-2b biosimilar (Laboratorio Varifarma)

LABORATORIO ELEA PHOENIX S.A.

Argentina

HERBARIUM LABORATORIO BOTANICO LTDA

Brazil

Laboratorio Magnachem International S.R.L.

Dominican Republic

Knight Therapeutics to Acquire Paladin in $120 Million Strategic Pharmaceutical Deal

Cingulate Stock Rated Buy by Roth/MKM, Anticipates $1.6B Sales Potential

NIAID's LMIV Spearheads Development of Novel Malaria Vaccines Targeting Transmission